LEESBURG, Va.–(BUSINESS WIRE)–K2M, Inc., the spinal device company developing innovative and simplified solutions for the treatment of complex spinal pathologies and procedures, today announced the SERENGETI® Minimally Invasive Retractor System received a 2010 Medical Design Excellence Award (MDEA). This is SERENGETI’s second industry award, as it was also recently recognized at the Orthopedics This Week Spine Technology Awards Banquet in November 2009.
SERENGETI features a unique flexible polymer retractor which is captured under the head of a cannulated screw and placed with the screw for secure, spine-based retraction. The retractor provides simplified access to the hard to reach L5 – S1 levels, as well as rod introduction for multi-level complex posterior instrumentation procedures.
MDEA entries were evaluated on the basis of their design and engineering features, including innovative use of materials, user-related functions that improve healthcare delivery and change traditional medical attitudes or practices, features that provide enhanced benefits to the patient, and the ability of the product development team to overcome design and engineering challenges so that the product meets its clinical objectives. A comprehensive review was performed by an impartial, multidisciplinary panel of third-party jurors with expertise in biomedical engineering, human factors, industrial design, medicine, and diagnostics.
“We are truly honored to be recognized as a 2010 MDEA Winner,” stated Eric Major, K2M’s President and CEO. “This achievement reflects K2M’s continued commitment to innovation and our ongoing goal to provide surgeons with new technologies to enhance patient care. We strive to develop more efficient approaches to address spinal surgery through very small incisions.”
About K2M
K2M, Inc. is an innovative spinal device company committed to the research, development, and commercialization of simplified solutions for the treatment of complex spinal pathologies and procedures. Chief Medical Officer, Chairman and co-founder, Dr. John Kostuik, former Chief of Spine Surgery at The Johns Hopkins University School of Medicine, drives K2M’s commitment to redefining the market. The company is recognized as a worldwide leader in providing unique technologies for the treatment of deformity, degenerative, trauma, and tumor spinal patients. K2M’s complete portfolio of next generation products includes: spinal stabilization systems, minimally invasive systems, and other advancing technologies such as motion preservation, annular repair, and nucleus replacement. Additional information is available online at www.K2M.com.
